Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration

Pathology

Volumn 46, Issue 5, 2014, Pages 416-423

  Panigrahy, Dipak ^a,b,c   Adini, Irit ^a,b   Mamluk, Roni ^a,b   Levonyak, Nicholas ^a   Bruns, Christiane J ^d   D'Amore, Patricia A ^b,e   Klagsbrun, Michael ^a,b   Bielenberg, Diane R ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Anti angiogenesis; Development; Endothelial cell; Hepatectomy; Hepatocyte; HGF; Liver; Neuropilin; VEGF

Indexed keywords

NEUROPILIN 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; LIVER REGENERATION; METABOLISM; MOLECULAR GENETICS; MOUSE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SEQUENCE HOMOLOGY; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; LIVER REGENERATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPILIN-1; SEQUENCE HOMOLOGY, NUCLEIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84903542048     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000121     Document Type: Article

References (44)

1. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007; 6: 273-86.
2. Brown LF, Detmar M, Claffey K, et al. Vascular permeability factor/ vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 1997; 79: 233-69.
3. Maharaj AS, Saint-Geniez M, Maldonado AE, et al. Vascular endothelial growth factor localization in the adult. Am J Pathol 2006; 168: 639-48.
4. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 2006; 312: 549-60.
5. Soker S, Takashima S, Miao HQ, et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92: 735-45.
6. Bielenberg DR, Klagsbrun M. Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 2007; 26: 421-31.
7. Ding BS, Nolan DJ, Butler JM, et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 2010; 468: 310-5.
8. Hora C, Romanque P, Dufour JF. Effect of sorafenib on murine liver regeneration. Hepatology 2011; 53: 577-86.
9. Berge M, Allanic D, Bonnin P, et al. Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling. J Hepatol 2011; 55: 866-75.
10. Fu L, KT, Iwabuchi K, et al. Interplay of neuropilin-1 and semaphorin 3A after partial hepatectomy in rats.World J Gastroenterol 2012; 18: 5034-41.
11. Bielenberg DR, Seth A, Shimizu A, et al. Increased smooth muscle contractility in mice deficient for neuropilin 2. Am J Pathol 2012; 181: 548-59.
12. West DC, Rees CG, Duchesne L, et al. Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem 2005; 280: 13457-64.
13. Sulpice E, Plouet J, Berge M, et al. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood 2008; 111: 2036-45.
14. Mizuno K, Nakamura T. Molecular characteristics of HGF and the gene, and its biochemical aspects. EXS 1993; 65: 1-29.
15. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure and implications for a central role in liver regeneration. J Gastroenterol Hepatol 1991; 6: 509-19.
16. Aoki M, Morishita R, Taniyama Y, Kaneda Y, Ogihara T. Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases. J Atheroscler Thromb 2000; 7: 71-6.
17. Zhang S, et al. Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Mol Cancer 2010; 9: 9.
18. Tao Q, Spring SC, Terman BI. Characterization of a new alternatively spliced neuropilin-1 isoform. Angiogenesis 2003; 6: 39-45.
19. Gagnon ML, Bielenberg DR, Gechtman Z, et al. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. Proc Natl Acad Sci USA 2000; 97: 2573-8.
20. Rossignol M, Gagnon ML, Klagsbrun M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics 2000; 70: 211-22.
21. Cackowski FC, Xu L, Hu B, et al. Identification of two novel alternatively spliced Neuropilin-1 isoforms. Genomics 2004; 84: 82-94.
22. Mamluk R, Klagsbrun M, Detmar M, et al. Soluble neuropilin targeted to the skin inhibits vascular permeability. Angiogenesis 2005; 8: 217-27.
23. Yamada Y, Takakura N, Yasue H, et al. Exogenous clustered neuropilin 1 enhances vasculogenesis and angiogenesis. Blood 2001; 97: 1671-8.
24. Greene AK, Puder M. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg 2003; 16: 99-102.
25. Bates D, Taylor GI, Minichiello J, et al. Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev Biol 2003; 255: 77-98.
26. Bielenberg DR, Hida Y, Shimizu A, et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest 2004; 114: 1260-71.
27. Francone TD, Landmann RG, Chen CT, et al. Novel xenograft model expressing human hepatocyte growth factor shows ligand-dependent growth of c-Met-expressing tumors. Mol Cancer Ther 2007; 6: 1460-6.
28. Mamluk R, Gechtman Z, Kutcher ME, et al. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. J Biol Chem 2002; 277: 24818-25.
29. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993; 90: 10705-9.
30. Baumwell S, Karumanchi SA. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract 2007; 106: c72-81.
31. Albuquerque RJ, Hayashi T, Cho WG, et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 2009; 15: 1023-30.
32. Herzog Y, Kalcheim C, Kahane N, et al. Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech Dev 2001; 109: 115-9.
33. Jubb AM, Strickland LA, Liu SD, et al. Neuropilin-1 expression in cancer and development. J Pathol 2012; 226: 50-60.
34. Hansel DE, Wilentz RE, Yeo CJ, et al. Expression of neuropilin-1 in highgrade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol 2004; 28: 347-56.
35. Jia C. Advances in the regulation of liver regeneration. Exp Rev Gastroenterol Hepatol 2011; 5: 105-21.
36. Kagoshima M, Kinoshita T, Matsumoto K, Nakamura T. Developmental changes in hepatocyte growth factor mRNA and its receptor in rat liver, kidney and lung. Eur J Biochem 1992; 210: 375-80.
37. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45-53.
38. Yoshida D, Akahoshi T, Kawanaka H, et al. Roles of vascular endothelial growth factor and endothelial nitric oxide synthase during revascularization and regeneration after partial hepatectomy in a rat model. Surg Today 2011; 41: 1622-9.
39. Taniguchi E, Sakisaka S, Matsuo K, et al. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001; 49: 121-30.
40. Parikh AA, Fan F, Liu WB, et al. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 2004; 164: 2139-51.
41. Stromblad S, Andersson G. The coupling between transforming growth factor-alpha and the epidermal growth factor receptor during rat liver regeneration. Exp Cell Res 1993; 204: 321-8.
42. Vanheule E, Fan YD, Van Huysse J, et al. Expression of placental growth factor in regenerating livers after partial hepatectomy in the rat. Eur J Gastroenterol Hepatol 2011; 23: 66-75.
43. Kawasaki T, KT, Bekku F Y, et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999; 126: 4895-902.
44. Sela S, Itin A, Natanson-Yaron S, et al. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ Res 2008; 102: 1566-74.